Literature DB >> 28114791

A simple, rapid and validated high-performance liquid chromatography method suitable for clinical measurements of human mercaptalbumin and non-mercaptalbumin.

Keiko Yasukawa1, Tatsuo Shimosawa1, Shigeo Okubo1, Yutaka Yatomi1.   

Abstract

Background Human mercaptalbumin and human non-mercaptalbumin have been reported as markers for various pathological conditions, such as kidney and liver diseases. These markers play important roles in redox regulations throughout the body. Despite the recognition of these markers in various pathophysiologic conditions, the measurements of human mercaptalbumin and non-mercaptalbumin have not been popular because of the technical complexity and long measurement time of conventional methods. Methods Based on previous reports, we explored the optimal analytical conditions for a high-performance liquid chromatography method using an anion-exchange column packed with a hydrophilic polyvinyl alcohol gel. The method was then validated using performance tests as well as measurements of various patients' serum samples. Results We successfully established a reliable high-performance liquid chromatography method with an analytical time of only 12 min per test. The repeatability (within-day variability) and reproducibility (day-to-day variability) were 0.30% and 0.27% (CV), respectively. A very good correlation was obtained with the results of the conventional method. Conclusions A practical method for the clinical measurement of human mercaptalbumin and non-mercaptalbumin was established. This high-performance liquid chromatography method is expected to be a powerful tool enabling the expansion of clinical usefulness and ensuring the elucidation of the roles of albumin in redox reactions throughout the human body.

Entities:  

Keywords:  Albumin; high-performance liquid chromatography; human mercaptalbumin; non-mercaptalbumin

Mesh:

Substances:

Year:  2017        PMID: 28114791     DOI: 10.1177/0004563217693257

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  10 in total

1.  A simple colorimetric assay to determine the concentration and proportion of human mercaptalbumin.

Authors:  Sawaki Tada; Keiko Yasukawa; Yutaka Yatomi; Tomoaki Uchiki
Journal:  Pract Lab Med       Date:  2022-05-23

2.  Evaluation of human nonmercaptalbumin as a marker for oxidative stress and its association with various parameters in blood.

Authors:  Rie Masudo; Keiko Yasukawa; Takahiro Nojiri; Naoyuki Yoshikawa; Hironori Shimosaka; Shinji Sone; Yumiko Oike; Akemi Ugawa; Tsutomu Yamazaki; Kentaro Shimokado; Yutaka Yatomi; Hitoshi Ikeda
Journal:  J Clin Biochem Nutr       Date:  2017-07-20       Impact factor: 3.114

3.  Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease Patients.

Authors:  Shinya Nakatani; Keiko Yasukawa; Eiji Ishimura; Ayumi Nakatani; Norikazu Toi; Hideki Uedono; Akihiro Tsuda; Shinsuke Yamada; Hitoshi Ikeda; Katsuhito Mori; Masanori Emoto; Yutaka Yatomi; Masaaki Inaba
Journal:  Sci Rep       Date:  2018-11-14       Impact factor: 4.379

4.  Establishment of a stable sampling method to assay mercaptoalbumin/non-mercaptoalbumin and reference ranges.

Authors:  Keiko Yasukawa; Masaya Sato; Takahiro Nojiri; Naoyuki Yoshikawa; Kazuharu Morita; Miyoko Kai; Yumiko Oike; Tsutomu Yamazaki; Hitoshi Ikeda; Yutaka Yatomi
Journal:  Pract Lab Med       Date:  2019-09-12

5.  Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 disease.

Authors:  Shin-Ichi Ueno; Taku Hatano; Ayami Okuzumi; Shinji Saiki; Yutaka Oji; Akio Mori; Takahiro Koinuma; Motoki Fujimaki; Haruka Takeshige-Amano; Akihide Kondo; Naoyuki Yoshikawa; Takahiro Nojiri; Makoto Kurano; Keiko Yasukawa; Yutaka Yatomi; Hitoshi Ikeda; Nobutaka Hattori
Journal:  Ann Clin Transl Neurol       Date:  2020-02-14       Impact factor: 4.511

6.  Redox state as assessed using the measurement of human non-mercaptalbumin in embryo culture media is associated with successful embryo development in human in vitro fertilization.

Authors:  Yoshika Kusumoto; Masaya Sato; Hitoshi Ikeda; Keiko Yasukawa; Xiaohui Tang; Yutaka Yatomi
Journal:  J Clin Biochem Nutr       Date:  2022-01-27       Impact factor: 3.179

7.  Non-mercaptalbumin is significantly associated with the coronary plaque burden and the severity of coronary artery disease.

Authors:  Shengpu Chou; Keiko Yasukawa; Yusuke Fujino; Midori Ishibashi; Mikiko Haraguchi; Masaya Sato; Hitoshi Ikeda; Sunao Nakamura; Yutaka Yatomi
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

8.  The effect of two formulations of carbon enterosorbents on oxidative stress indexes and molecular conformation of serum albumin in experimental animals exposed to CCl4.

Authors:  Veronika Sarnatskaya; Victor Mikhailenko; Igor Prokopenko; Bogdan I Gerashchenko; Oksana Shevchuk; Larysa Yushko; Alexei Glavin; Lyudmila Makovetska; Larysa Sakhno; Oleksii Sydorenko; Oleksandr Kozynchenko; Vladimir Nikolaev
Journal:  Heliyon       Date:  2020-01-06

Review 9.  Oxidized Albumin as a Mediator of Kidney Disease.

Authors:  Stefanny M Figueroa; Patricio Araos; Javier Reyes; Basile Gravez; Jonatan Barrera-Chimal; Cristián A Amador
Journal:  Antioxidants (Basel)       Date:  2021-03-08

Review 10.  Serum Albumin Redox States: More Than Oxidative Stress Biomarker.

Authors:  Fuka Tabata; Yasuaki Wada; Satomi Kawakami; Kazuhiro Miyaji
Journal:  Antioxidants (Basel)       Date:  2021-03-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.